独占：Cobotのセールスリードは、給与に関する苦情から4日後に解雇されたと主張

RUNTIMEWIRE INVESTIGATION — Exclusive

Original reporting by RuntimeWire.

Why it matters

Cobot's dispute exposes a recurring fault line in enterprise robotics: salespeople build long-cycle markets before deployments produce revenue, making written commission rules and account ownership critical during restructurings.

In late April, Alison Tran flew from her home in Florida to the headquarters of Collaborative Robotics, the well-funded Silicon Valley startup better known as Cobot. She had spent more than a year selling the company’s robots to hospitals and life-sciences businesses. Now she wanted an answer to a basic question: How, exactly, would Cobot pay her for those sales?

When Tran joined the company in January 2025, Cobot offered her a $180,000 salary and as much as $80,000 in variable compensation, according to a lawsuit she filed last week in Santa Clara County Superior Court. Yet Tran says the company never gave her a written commission plan—not for 2025, and not for 2026. On April 30, she raised the issue again with the executive who had recently become her manager.

Four days later, Cobot fired her.

The company told Tran that a restructuring had eliminated her position. The timing was striking. Earlier that day, according to the complaint, colleagues had acknowledged her “highly developed healthcare pipeline” during a regular sales meeting. When Cobot dismissed her by video call that afternoon, it immediately cut her access to email and customer records. Her active opportunities, including several large prospective healthcare deals, were reassigned to men, she alleges.

Tran says she was the only woman on Cobot’s three-person sales team. The company retained a younger male colleague. It later began recruiting for another healthcare account manager.

Those events are now the center of an 18-count lawsuit accusing Cobot and Tran’s former manager, Justin Weissert, of gender and age discrimination, retaliation, harassment, withholding compensation, and other violations of California employment law. The filing also reveals staff cuts that Cobot did not publicly announce: Weissert and several employees were dismissed on April 20, the complaint says, followed by Tran and other workers on May 4.

Cobot has not answered the complaint, and no court has tested Tran’s allegations. The filing gives only her version of events. Still, it raises a question that reaches beyond one employment dispute. At a startup racing to turn impressive machines into a durable business, who gets paid for creating a market—and what happens when the company keeps the market but dismisses the person who built it?

労働力不足に対応して作られた企業

Cobot was founded in 2022 by Brad Porter, a former vice president of Amazon Robotics. Its first machine, Proxie, is designed to move carts, supplies, specimens, and other materials through places built for people: hospital corridors, loading docks, laboratories, and factory floors.

The pitch found an eager audience. In April 2024, Cobot raised $100 million at a valuation above $500 million in a round led by General Catalyst, with participation from Sequoia Capital, Khosla Ventures, and Mayo Clinic. The financing brought its total funding above $140 million, according to Reuters. Cobot had 35 employees and planned to double its workforce within a year.

By the time Cobot publicly introduced Proxie in November 2024, it could name an enviable group of early customers: Maersk, Mayo Clinic, Moderna, Owens & Minor, and Tampa General Hospital. Three came from healthcare and life sciences, fields where moving material is essential, expensive, and difficult to automate around patients and staff.

Tran arrived two months later. Her initial remit spanned healthcare, logistics, hospitality, manufacturing, and government. In March 2025, Cobot expanded her title to senior sales lead for healthcare and enterprise, placing her in charge of healthcare, life-sciences, and other large accounts, she alleges.

This was the less glamorous side of a robotics company’s work. Proxie could be demonstrated in a video. Enterprise adoption had to be built account by account, through procurement reviews, site visits, pilots, and negotiations involving operators, executives, and technical teams. In healthcare, a salesperson can spend months developing an opportunity before a purchase or deployment produces revenue.

That long interval makes a commission plan consequential. It determines when a sale is considered earned, how credit is divided, and whether an employee is paid if a deal closes after the employee leaves. Without a written formula, a salesperson may create a valuable pipeline while having little certainty about the value of her own work.

Tran alleges that she repeatedly asked Cobot and Weissert to define those terms. Her complaint does not include the correspondence or calculate the commissions she believes Cobot owes her. It says only that the written plan never arrived.

California law generally requires commission agreements to be written and to explain how commissions are computed and paid. One issue in the case will be whether Tran’s variable compensation qualifies as a commission under that law. Another will be how California’s wage rules apply to an employee who lived and usually worked in Florida but traveled to Cobot’s Santa Clara office.

The absence of those answers did not prevent Cobot from using Tran’s work. According to the complaint, the company continued tracking and discussing her healthcare opportunities until the day it fired her.

「規模拡大の準備ができている」

Publicly, Cobot entered 2026 in a triumphant mood. In a January LinkedIn post, an executive said Proxie had moved more than 130,000 carts, carried six million specimens, and completed more than 10,000 operating hours. “We’re ready for scale,” he wrote, tagging both Tran and Weissert among the company’s go-to-market employees.

The internal picture changed quickly.

On April 20, Cobot dismissed Weissert and several other employees, according to Tran’s complaint. Weissert had joined the company in early 2025 to lead a group that helped customers adopt and deploy Proxie. After his departure, Tran began reporting to a Cobot founder who also held an operations role.

On April 30 came the Santa Clara meeting and Tran’s renewed request for a compensation plan. On May 4 came the pipeline review, followed hours later by her termination. Cobot said it was eliminating her position as part of a restructuring.

There are facts in the complaint that may help the company defend that explanation. Tran acknowledges that Cobot dismissed other employees during the same period, including women. She says another worker over 40 was fired on May 4. A broad reduction can be legitimate even when it falls painfully on an employee who recently complained about pay.

Tran’s case will therefore turn on the choices Cobot made inside that reduction. She alleges that the company kept a younger male salesperson, gave her deals to male colleagues, and later sought another employee to perform healthcare account work. Internal messages, hiring approvals, compensation records, and the criteria used to select employees for dismissal may prove more important than the four-day interval alone.

職を失った後の業務

Cobot is currently advertising a Strategic Account Manager for Healthcare. The employee would lead the relationship with one of Cobot’s most important enterprise customers, find ways to expand the account, and coordinate the sales, service, and deployment teams. The posting favors candidates near Minneapolis but permits remote work for people willing to travel as much as 65 percent of the time. Syndicated listings put annual compensation at $200,000 to $240,000.

The geography is conspicuous. Cobot has publicly identified Mayo Clinic, based in Rochester, Minnesota, as both an investor and an early customer. The listing does not identify the account, and there is no public evidence that the role is assigned to Mayo.

The position is also narrower than the one Tran describes. She says she built a portfolio across healthcare, life sciences, and enterprise sales. The new opening centers on the expansion of one established customer. Cobot could reasonably argue that the jobs are different.

But the listing complicates the cleanest meaning of “position eliminated.” Healthcare sales work remained important enough to support a role whose reported pay overlaps closely with Tran’s target compensation. The legal question is whether Cobot abolished her job, reorganized it, or used a restructuring to place the same valuable relationships in other hands.

Tran氏の広範な差別主張は同じ不均衡から出発している。彼女は、実質的に同様の仕事をしている男性同僚よりも基本給が低かったと述べ、男性エンジニアと仕事をするのに困難を経験したと主張している。ここでは訴状が弱くなる。男性同僚の給与を特定しているわけでも、提案された比較対象の経験を詳述しているわけでも、嫌がらせの主張の背景にある具体的な発言や出来事を列挙しているわけでもない。これらの欠落は訴訟提起の段階で請求を退ける理由にはならないが、公的記録は職場文化よりも時期と報酬についての情報がはるかに充実している状態になっている。

訴状にはほかにも限界がある。Tran氏はオファーレター、提案された離職合意書、パイプラインレポート、苦情を記録したメッセージを添付していない。彼女はCalifornia Civil Rights Departmentから即時のright-to-sue通知を取得しており、これは請求人が直接裁判に進むことを可能にする手続きだ。同部門は事件の当否を調査していない。

これらは訴えを棄却すべき理由というよりは慎重になる理由である。雇用紛争は、原告が自身の主張を裏付けたり覆したりできる企業記録にアクセスする前に提起されることが多い。Cobotの対応—そして最終的には同社の内部文書—が、訴状に記された時系列が報復を反映するものか偶然にすぎないかを決定するだろう。

ロボットの発表

Tran氏の解雇から7週間後、CobotはProxieの第2世代を発表した。

同社は新しい機体が職場内を移動し、二本のアームで物体を操作し、人間のディスパッチャーなしにタスクを識別できると述べた。Cobotは以前のロボットが12,627時間の稼働時間を記録し、4,000万ポンド以上の材料を移動させたと報告した。Proxie Gen 2は6月22日から注文可能になり、月額5,000ドルからの開始価格だとaccording to the company。

この発表はTran氏が入社して以来Cobotがどれだけ進展したかを示した。同社はProxieが動作することを証明する段階から、大口顧客に大規模導入を納得させる段階へと移行していた。その移行は営業組織を変え得る：幅広い事業開発から、命名されたアカウント、導入、拡張へと変わるのだ。また、初期段階で作られた機会について誰が功績を主張するかを巡る争いを生むこともある。

Tran氏は、Cobotが将来の雇用を開示させ、Cobotが将来の雇用主に連絡することを許すような制限を含む離職合意書を提示したと主張している。彼女はそれに署名することを拒否した。彼女の訴訟はそれらの条項を違法な競業禁止条項として特徴づけているが、合意書は添付されておらず、その正確な文言は訴状から評価することはできない。

彼女は未払いの報酬、損害賠償、罰金、弁護士費用、そして復職または将来の逸失賃金のいずれかを求めている。事件は Alison Tran v. Collaborative Robotics Inc. and Justin Weissert, No. 26CV499596, in Santa Clara County Superior Court である。

Cobotは今、ロボットでは補えない物語の部分、すなわち業務の背後にある人間の意思決定の記録を提示しなければならない。なぜ同社はTran氏のコミッション条件を文書化しなかったのか。誰が彼女の医療機会を受けたのか。Cobotはいつ新しいアカウント管理の役割を承認したのか。そして、支払い方法について改めて尋ねた後わずか4日で営業チームで唯一の女性がいなくなったのはなぜか。

RuntimeWire contacted Cobot and counsel for Alison Tran for comment. Because no verified current contact information for Justin Weissert was publicly available, RuntimeWire asked Cobot to forward the request or identify his representative.

https://www.dropbox.com/scl/fi/e7laxedtclcncle3tn89v/document.pdf?rlkey=6wrasyj6l4u1l2exel3xokr8y&st=amya3eoo&dl=1